NKTR
NEKTAR THERAPEUTICS
NASDAQ · Healthcare · Biotechnology · US
$67.10
−1.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 55.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.54x
- Price / sales
- 41.97x
- Price / cash flow
- -9.80x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 31.92x
- EV / EBITDA
- -12.97x
- EV / EBIT
- -13.28x
- Market cap
- $2.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026